StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

AnaptysBio's EV/EBITDA was 4.2× on Oct 19, 2026, against 4.9× a year earlier. Over the last 2 years it ranged from 0.9× to 31.6×, with a median of 4.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20264.2×−0.1
2025Dec 31, 20254.2×−21.3
2022Jan 31, 202225.5×−6.1
2021Dec 31, 202131.6×–

More AnaptysBio figures

See a number that looks wrong?